Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 21, 2008
Preventing growth of brain tumors by creating a zone of resistance
Casey A Maguire, Dimphna H Meijer, Stanley G LeRoy, et al.
Molecular Therapy. Methods & Clinical Development
|
April 19, 2021
AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear
Maryna V Ivanchenko, Killian S Hanlon, Daniel M Hathaway, et al.
Human Gene Therapy
|
October 26, 2018
Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy
Yi Gong, Anna Berenson, Fiza Laheji, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 9, 2012
Microvesicle-associated AAV vector as a novel gene delivery system
Casey A Maguire, Leonora Balaj, Sarada Sivaraman, et al.
Neuro-Oncology
|
April 13, 2019
Gene therapy with apoptosis-associated speck-like protein, a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo
Sherif G Ahmed, Ahmed Abdelnabi, Casey A Maguire, et al.
Molecular Oncology
|
August 20, 2020
AAV-mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response
Yujia Xia, Jiayi He, Hongji Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
September 25, 2023
<i>In vivo</i> selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cord
Killian S Hanlon, Ming Cheng, Demitri De La Cruz, et al.
Human Molecular Genetics
|
August 18, 2020
Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation
Ana Griciuc, Anthony N Federico, Jeyashree Natasan, et al.
Human Gene Therapy
|
June 15, 2021
The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration
Adam Beharry, Yi Gong, James C Kim, et al.
Molecular Therapy. Methods & Clinical Development
|
September 20, 2019
Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1
Shilpa Prabhakar, Pike See Cheah, Xuan Zhang, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 21, 2008
Preventing growth of brain tumors by creating a zone of resistance
Casey A Maguire, Dimphna H Meijer, Stanley G LeRoy, et al.
Molecular Therapy. Methods & Clinical Development
|
April 19, 2021
AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear
Maryna V Ivanchenko, Killian S Hanlon, Daniel M Hathaway, et al.
Human Gene Therapy
|
October 26, 2018
Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy
Yi Gong, Anna Berenson, Fiza Laheji, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 9, 2012
Microvesicle-associated AAV vector as a novel gene delivery system
Casey A Maguire, Leonora Balaj, Sarada Sivaraman, et al.
Neuro-Oncology
|
April 13, 2019
Gene therapy with apoptosis-associated speck-like protein, a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo
Sherif G Ahmed, Ahmed Abdelnabi, Casey A Maguire, et al.
Molecular Oncology
|
August 20, 2020
AAV-mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response
Yujia Xia, Jiayi He, Hongji Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
September 25, 2023
<i>In vivo</i> selection in non-human primates identifies superior AAV capsids for on-target CSF delivery to spinal cord
Killian S Hanlon, Ming Cheng, Demitri De La Cruz, et al.
Human Molecular Genetics
|
August 18, 2020
Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation
Ana Griciuc, Anthony N Federico, Jeyashree Natasan, et al.
Human Gene Therapy
|
June 15, 2021
The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration
Adam Beharry, Yi Gong, James C Kim, et al.
Molecular Therapy. Methods & Clinical Development
|
September 20, 2019
Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1
Shilpa Prabhakar, Pike See Cheah, Xuan Zhang, et al.
Page
of 8